These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35723012)

  • 1. Validity of fatty liver disease indices in the presence of alcohol consumption.
    Danielsson O; Nano J; Pahkala K; Rospleszcz S; Lehtimäki T; Schlett CL; Kähönen M; Bamberg F; Raitakari O; Peters A; Nissinen MJ; Åberg FO
    Scand J Gastroenterol; 2022 Nov; 57(11):1349-1360. PubMed ID: 35723012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.
    Cuthbertson DJ; Weickert MO; Lythgoe D; Sprung VS; Dobson R; Shoajee-Moradie F; Umpleby M; Pfeiffer AF; Thomas EL; Bell JD; Jones H; Kemp GJ
    Eur J Endocrinol; 2014 Nov; 171(5):561-9. PubMed ID: 25298375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
    Chen J; Mao X; Deng M; Luo G
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
    Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
    World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
    Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
    World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease].
    Arteaga I; Buezo I; Expósito C; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P; Caballería L
    Gastroenterol Hepatol; 2014 Nov; 37(9):503-10. PubMed ID: 24746708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
    Long MT; Massaro JM; Hoffmann U; Benjamin EJ; Naimi TS
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1831-1841.e5. PubMed ID: 31734449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK
    Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women.
    Lau K; Baumeister SE; Lieb W; Meffert PJ; Lerch MM; Mayerle J; Völzke H
    Aliment Pharmacol Ther; 2015 Mar; 41(5):467-76. PubMed ID: 25588768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting.
    Jung TY; Kim MS; Hong HP; Kang KA; Jun DW
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.
    Zeng J; Sun C; Sun WL; Chen GY; Pan Q; Yan SY; Xu ZJ; Chen YW; Fan JG
    J Dig Dis; 2017 Apr; 18(4):229-236. PubMed ID: 28296249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.
    Morinaga M; Kon K; Uchiyama A; Fukada H; Fukuhara K; Yaginuma R; Nakadera E; Yamashina S; Ikejima K
    Hepatol Int; 2022 Apr; 16(2):348-358. PubMed ID: 35060066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
    Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
    Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.